Sure. AA for kids, despite the BLA having just been denied. The FDA, again, recommending an RCT.
AA for CHF, despite an unclear mechanism, unconvincing data, expert panel being confused and skeptical, and being a very invasive procedure.
AA for CLBP, despite the failure of the phase 3.
If you think there's a quick way to success here you are fooling yourself.
Do yourself a favour, Nippy. Go for a walk and think about this investment thesis of yours.
If you won't change your thesis despite new developments, ask yourself why.
Ann: Update on BLA for Graft Versus Host Disease, page-619
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.5¢ |
Change
-0.040(4.02%) |
Mkt cap ! $1.093B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 95.0¢ | $1.475M | 1.513M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 112366 | 95.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 41256 | 47 |
View Market Depth
| Last trade - 13.52pm 20/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |